Insmed Incorporated (NASDAQ:INSM) Receives Consensus Rating of Buy from Analysts

Insmed Incorporated (NASDAQ:INSM – Get Free Report) has been assigned an average recommendation of “Buy” from the eleven ratings firms that are presently covering the stock, MarketBeat.com reports. Eleven equities research analysts have rated the stock with a buy recommendation. The average 1-year target price among brokers that have updated their coverage on the stock […]

Related Keywords

United States ,Sara Bonstein ,Martina Md Flammer ,Cantor Fitzgerald ,Insmed Incorporated ,Long Focus Capital Management ,Securities Exchange Commission ,Jpmorgan Chase Co ,William Blair Investment Management ,Wells Fargo Company ,Get Free Report ,Exchange Commission ,Blair Investment Management ,Focus Capital Management ,Atom Investors ,Get Free ,Insmed Daily ,Insmed ,Nasdaq Insm ,Insm ,Medical ,Ratings ,Consensus ,